58 filings
Page 2 of 3
8-K
5100vv2ui5lzjd4
9 Jan 23
Results of Operations and Financial Condition
9:00am
8-K
rirjxo
5 Dec 22
Cost Associated with Exit or Disposal Activities
4:22pm
8-K
ud1vjv 4j
14 Nov 22
Exagen Inc. Reports Third Quarter 2022 Results
4:08pm
8-K
x8794ecs5sa
20 Oct 22
Exagen Announces Appointment of John Aballi as CEO
4:05pm
8-K
5z0utgjhfe
15 Sep 22
Entry into a Material Definitive Agreement
4:03pm
8-K
8acvlk2
4 Aug 22
Exagen Inc. Reports Second Quarter 2022 Results
4:06pm
8-K
ur7q 4hbcfypcnkj
21 Jun 22
Submission of Matters to a Vote of Security Holders
8:30am
8-K
y0xxf
11 May 22
Exagen Inc. Reports First Quarter 2022 Results
4:05pm
8-K
geuhsry1j
28 Apr 22
Departure of Directors or Certain Officers
4:11pm
8-K
08jnf
22 Mar 22
Exagen Inc. Reports Fourth Quarter and Full Year 2021 Results
4:05pm
8-K
awtrx
10 Jan 22
Regulation FD Disclosure
8:25am
8-K
ffu4qz2jfzj
10 Nov 21
Exagen Inc. Reports Third Quarter 2021 Results
4:05pm
8-K
59p1bb
25 Oct 21
Exagen Inc. Announces $27.2 Million Debt Refinancing
8:26am
8-K
4lrfrk
19 Oct 21
Entry into a Material Definitive Agreement
4:05pm
8-K
j11z9 67xqx7rl93y1
27 Aug 21
Entry into a Material Definitive Agreement
8:25am
8-K
qcokalxknmk2 2biq
9 Aug 21
Exagen Inc. Reports Second Quarter 2021 Results
4:05pm
8-K
b22q1xl
30 Jul 21
Exagen Appoints Ana Hooker to Board of Directors
8:25am
8-K
8uqapih2msq6hzolvnp8
21 Jun 21
Submission of Matters to a Vote of Security Holders
8:30am
8-K
gf6q538rm
11 May 21
Exagen Inc. Reports First Quarter 2021 Results
4:06pm
8-K
hytbws 4kqzwg1yygs
23 Mar 21
Exagen Inc. Announces Proposed Public Offering of Common Stock
4:16pm